Abionic SA

Company founded: October 2010

Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to supply physicians with a novel diagnostic tool and thereby provide patients with personal allergy profiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.

Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.

Abionic SA is a privately held high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab. The company also benefits from coaching of Genilem, the A3 Angels mentoring program and the CTI coaching.

Abionic was founded in 2010 by former scientists of the biomedical optics laboratory (LOB) at EPFL. The headquarters are located in Lausanne, Switzerland.

Milestones / News

Milestone 22.05.2015

Start of commercialization and incorporation of US subsidiary in Boston.

Funding Activity 14.10.2014

Abionic closes CHF 3.8 million serie B financing

Milestone 17.09.2014

3rd Swiss best start-up

Milestone 23.05.2013

Winner of the Venture4i 2013 Trophy

Milestone 01.05.2013

Start of clinical trials

Milestone 15.04.2013

Abionic wins international Local to Global Award

Milestone 20.12.2012

Abionic achieves CE-Marking for revolutionary allergy diagnosis platform

Milestone 29.11.2012

Abionic ranked 7th best Swiss Startup in 2012

Funding Activity 27.04.2012

Abionic finalized the closing of a CHF 2 million (USD 2.2 million) first financing round

Milestone 05.04.2012

Abionic is a Finalist for the 2012 Red Herring Top 100 Europe Award

Milestone 21.03.2012

Abionic Ltd receives the ISO 9001 and ISO 13485 certification

Milestone 15.12.2011

Abionic among the finalists for the European ACES Academic Enterprise awards

Milestone 13.10.2011

Abionic ranked 32nd best Swiss Startup in 2011

Milestone 19.09.2011

Abionic participated to the Silicon Valley expedition organized by the IMD business school of Lausanne

Milestone 29.06.2011

Abionic receives the De Vigier 2011 Award

Milestone 20.06.2011

Abionic nominates Tim Dyer as New Member of the Board of Directors

Documents

Videos and Presentations

SRF/ECO: Abionic ist einen Schritt weiter

>

Abionic featured on French TV channel ARTE

TV report from Reuters: Abioscope scratches itch for fast allergy testing

>

See Abionic on French National TV France3 (only in French)

>

Abionic featured in the Polytech Ventures movie

>

See Abionic on Swiss National TV (only in German)

Two million Swiss francs for an allergy-detecting device (EPFL movie)

>

Nicolas Durand presents Abionic (3min)

>

>

Abionic SA

Nicolas Durand

EPFL Innovation Park,Bât B
1015 Lausanne

http://www.abionic.com

Contact

Sharing

Links

PARTNERS